FdaApplication
BLA 203313
Identifiers
- fda_app_no: BLA203313
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 2015-09-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RYZODEG 70/30 | INSULIN ASPART; INSULIN DEGLUDEC | 90 UNITS/3ML;210 UNITS/3ML (30 UNITS/ML | Injection |
1 product